Accelerating Growth.
Pivoting to a Stronger Future
Growth is not just about expanding scale. It is about strengthening capabilities, adapting to evolving opportunities, and building a differentiated, future-ready business.
At Jubilant Ingrevia, our journey has been shaped by chemistry, innovation, and trusted customer partnerships. Over the years, we have built a strong foundation anchored in integrated manufacturing capabilities, global leadership positions, deep chemistry expertise, and enduring relationships with customers worldwide.
Today, we are navigating a deliberate transformation: from a product-led manufacturing organisation to a service-led Specialty Chemicals and CDMO solutions partner, delivering customised, high-value solutions. This pivot is enabling a more predictable, innovation-driven, and resilient business with greater visibility into long-term growth opportunities.
Our calibrated investments in advanced manufacturing infrastructure, R&D capabilities, technology platforms, and customer-focused verticals have translated into tangible outcomes. With more than ₹2,000 Crore invested over the last three years, we have created niche, high-value platforms across Specialty Chemicals, CDMO, Nutrition, Personal Care, and Semiconductor applications.
A cornerstone of this transformation is the accelerated expansion of the CDMO business. We see CDMO as a scalable growth engine, aligned with global outsourcing trends, the China+1 shift, and increasing demand for reliable manufacturing partners. A key milestone this year was the commissioning of our multipurpose Agro CDMO facility and commencement of dispatches for USD 300 million to a leading global agrochemical innovator. Our pipeline continues to gain momentum, with 100+ active opportunities representing ₹3,400+ Crore in peak revenue potential. The upcoming Multi-Purpose Plant (MPP) at Gajraula will further strengthen our ability to capture future opportunities.
Beyond CDMO, we are deepening our presence across high-potential segments. The acquisition of Remidex Pharma Pvt Ltd. will enhance our position in Vitamin and Mineral Premixes, expanding our Human Nutrition business. Our Personal Care portfolio continues to scale rapidly, while the upcoming dedicated Semiconductor R&D Lab in Greater Noida is unlocking new growth opportunities.
Guiding this transformation is our Pinnacle Strategy, built around five strategic pillars — Customer Centricity, World-Class Safe Operations, Innovation & Technology, Sustainability, and People & Organisation. These pillars enable us to expand customer partnerships, boost innovation and operational excellence, and advance sustainable practices, aimed at creating a steadfast, future-focused organisation. As we move forward, we remain committed to scaling high-potential businesses, accelerating innovation-led solutions, and delivering sustainable growth and value creation.